Which antiplatelet agents are preferred for patients with Non ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)?
Preferred options for patients with Non ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) are eptifibatide or tirofiban (Level of Evidence: B). Aspirin is the established first-line therapy and a loading dose of non enteric-coated aspirin 162 mg to 325 mg is the initial antiplatelet therapy.